The present invention comprises a group of compounds that effectively inhibit angiogenesis. More specifically, nitrogen-substituted thalidomide analogs and di-substituted thalidomide analogs have been shown to inhibit angiogenesis. Importantly, these compounds can be administered orally.
本发明涵盖了一组有效抑制血管生成的化合物。更具体地说,已经证明氮取代苯酰胺类和二取代苯酰胺类
硫酰胺类化合物能够抑制血管生成。重要的是,这些化合物可以经口服给药。